SLFN11 and colorectal carcinoma: Interestingly, SLFN11 expression can be driven by gain‐of‐function JAK mutations [38] and activation of the JAK–STAT pathway was linked with hyperresponsiveness to IFN‐γ in an MSI‐H CRC cell line [39].